Sarah Cavanaugh
Senior Vice President
Corporate Affairs and Administration
|
Sep 15, 2020 10:40 AM EDT |
Cantor Virtual Global Healthcare Conference Fireside Chat
|
|
Sep 16, 2020 9:00 AM EDT |
HC Wainwright & CO 22nd Annual Global Investment Virtual Conference Fireside Chat
|
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.
About
Investors & Media
© 2020 Celldex Therapeutics, All rights reserved | Site Map | Privacy Policy | Terms of Use | Contact
